Businessweek Archives

Transatlantic Drugmakers Team Up

In Business This Week


The battle among drug companies for over-the-counter shelf space is heating up. On July 28, British drugmakers Glaxo Holdings and Wellcome announced separate plans to team up with Warner-Lambert. Glaxo and Warner-Lambert plan to form a joint venture aimed at developing and marketing a version of Glaxo's $3.2 billion ulcer drug, Zantac. Wellcome and Warner-Lambert have established a partnership that will do the same for a version of Wellcome's $1 billion antiviral medication,Zovirax.

The British companies are hoping that Warner-Lambert's marketing muscle can help stave off share erosion as patent expiration--and generic competition--loom for Zovirax and Zantac.

News on Wellcome's AIDS drug, AZT: A North Carolina court recently upheld the company's exclusive patent rights, effectively barring two U.S. rivals from selling generic clones. EDITED BY KEITH H. HAMMONDS

Later, Baby

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

blog comments powered by Disqus